ICS-formoterol

2026 Global Initiative for Asthma (GINA) Strategy Report: Executive Summary and Key Changes

A concise, practice-focused summary of the 2026 GINA Strategy Report, highlighting new recommendations on inhaled corticosteroid–formoterol (AIR) strategies, severe asthma biologic guidance, and acute care updates.

ICS–Formoterol Users Show Lower Reported Adherence but Less SABA Use: Real‑World Evidence from the MASK‑air Asthma App